Teva, others talk settlements with feds in yearslong generics price fixing probe: report

Teva and other generic companies have been engaged in settlement talks with federal prosecutors over alleged price fixing for the last six months, Bloomberg reports. The talks could fail to yield deals, and there's no timetable for any potential agreements. Prosecutors have been looking into alleged price fixing for several years.